ProfileGDS4718 / 215573_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 20% 19% 17% 27% 20% 16% 26% 19% 20% 26% 19% 20% 15% 20% 25% 24% 20% 19% 14% 27% 25% 23% 20% 19% 19% 21% 32% 24% 16% 16% 17% 19% 21% 17% 18% 16% 17% 18% 16% 25% 20% 21% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.528930
GSM549102patient 115, normal, homogenized [OPG study]4.154520
GSM549104patient 119, normal, homogenized [OPG study]4.092619
GSM549108patient 138, normal, homogenized [OPG study]4.0534617
GSM549119patient 077, normal, homogenized [OPG study]4.422827
GSM549133patient 032, cancer, homogenized [OPG study]4.1115720
GSM549139patient 042, cancer, homogenized [OPG study]3.9693716
GSM549099patient 107, normal, homogenized [OPG study]4.4038626
GSM549109patient 139, normal, homogenized [OPG study]4.1350319
GSM549110patient 046, normal, homogenized [OPG study]4.1343520
GSM549114patient 063, normal, homogenized [OPG study]4.3309126
GSM549122patient 082, normal, homogenized [OPG study]4.1266319
GSM549134patient 033, cancer, homogenized [OPG study]4.1327320
GSM549136patient 036, cancer, homogenized [OPG study]3.9274515
GSM549140patient 044, cancer, homogenized [OPG study]4.0953420
GSM549111patient 047, normal, homogenized [OPG study]4.3196525
GSM549113patient 057, normal, homogenized [OPG study]4.2555824
GSM549132patient 031, cancer, homogenized [OPG study]4.1256720
GSM549137patient 038, cancer, homogenized [OPG study]4.0896319
GSM549142patient 047, cancer, homogenized [OPG study]4.0152214
GSM549100patient 110, normal, homogenized [OPG study]4.4258427
GSM549107patient 135, normal, homogenized [OPG study]4.3122625
GSM549115patient 068, normal, homogenized [OPG study]4.194123
GSM549116patient 072, normal, homogenized [OPG study]4.112520
GSM549120patient 078, normal, homogenized [OPG study]4.1115719
GSM549131patient 030, cancer, homogenized [OPG study]4.0479219
GSM549118patient 074, normal, homogenized [OPG study]4.1804621
GSM549129patient 027, cancer, homogenized [OPG study]4.6558132
GSM549123patient 088, normal, homogenized [OPG study]4.2850624
GSM549124patient 006, cancer, homogenized [OPG study]4.0396216
GSM549126patient 015, cancer, homogenized [OPG study]3.986716
GSM549128patient 025, cancer, homogenized [OPG study]3.9964717
GSM549103patient 117, normal, homogenized [OPG study]4.1316619
GSM549117patient 073, normal, homogenized [OPG study]4.153221
GSM549138patient 041, cancer, homogenized [OPG study]4.0058217
GSM549141patient 045, cancer, homogenized [OPG study]4.0119318
GSM549130patient 028, cancer, homogenized [OPG study]4.0125416
GSM549101patient 111, normal, homogenized [OPG study]4.057417
GSM549105patient 128, normal, homogenized [OPG study]4.06618
GSM549106patient 134, normal, homogenized [OPG study]3.9443416
GSM549112patient 048, normal, homogenized [OPG study]4.332325
GSM549125patient 011, cancer, homogenized [OPG study]4.1683320
GSM549127patient 024, cancer, homogenized [OPG study]4.1513421
GSM549135patient 035, cancer, homogenized [OPG study]4.1113820